IL6 and metabolic dysfunction-associated steatotic liver disease: Notably, MASLD might dysregulate the “liver–lung axis”—the bidirectional network in which alveolar macrophages secrete cytokines (e.g., IL-1, IL-6, and TNF-α) during pneumonia triggering the liver acute-phase response, which in turn modulates lung immune responses [15].